0001181431-13-017026.txt : 20130314
0001181431-13-017026.hdr.sgml : 20130314
20130314180210
ACCESSION NUMBER: 0001181431-13-017026
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130311
FILED AS OF DATE: 20130314
DATE AS OF CHANGE: 20130314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaldor Stephen W
CENTRAL INDEX KEY: 0001507502
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34641
FILM NUMBER: 13691570
MAIL ADDRESS:
STREET 1: C/O FURIEX PHARMACEUTICALS, INC.
STREET 2: 3900 PARAMOUNT PARKWAY, SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001484478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271197863
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3900 PARAMOUNT PARKWAY
STREET 2: SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-456-7800
MAIL ADDRESS:
STREET 1: 3900 PARAMOUNT PARKWAY
STREET 2: SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: PPD Therapeutics, Inc.
DATE OF NAME CHANGE: 20100218
4/A
1
rrd374145.xml
FORM 4/A
X0306
4/A
2013-03-11
2013-03-13
0
0001484478
Furiex Pharmaceuticals, Inc.
FURX
0001507502
Kaldor Stephen W
C/O FURIEX PHARMACEUTICALS, INC.
3900 PARAMOUNT PARKWAY, SUITE 150
MORRISVILLE
NC
27560
1
0
0
0
Common Stock
2013-03-11
4
M
0
5379
13.94
A
5379
D
Common Stock
2013-03-11
4
S
0
5379
41.74
D
0
D
Common Stock
2013-03-12
4
M
0
973
13.94
A
973
D
Common Stock
2013-03-12
4
S
0
973
40.71
D
0
D
Common Stock
2013-03-13
4
M
0
1648
13.94
A
1648
D
Common Stock
2013-03-13
4
S
0
1648
39.96
D
0
D
Stock Options (to buy)
13.94
2013-03-11
4
M
0
5379
0.00
D
2021-05-19
Common Stock
5379
7633
D
Stock Options (to buy)
13.94
2013-03-12
4
M
0
973
0.00
D
2021-05-19
Common Stock
973
6660
D
Stock Options (to buy)
13.94
2013-03-13
4
M
0
1648
0.00
D
2021-05-19
Common Stock
1648
5012
D
Stock Options (to buy)
13.45
2021-10-12
Common Stock
8825
8825
D
Stock Options (to buy)
18.22
2022-05-24
Common Stock
17500
17500
D
These options and underlying shares were previously incorrectly reported as 8,000 in the Form 4.
This exercise of options was previously incorrectly reported as being included in the 8,000 referenced in footnote (1).
The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
This Form 4 is being amended to report all transactions that occurred on March 11 and 12, 2013, although the only corrections are those identified in footnote (1). We have also included transactions not previously reported regarding an option exercise and shares sold on March 13, 2013.
/s/ Alexander M. Donaldson, by Power of Attorney
2013-03-14